{
  "abstract": "CDigital therapeutics (DTx) are software-based medical devices that deliver evidence-based therapeutic interventions directly to patients. While the clinical use of DTx is expanding rapidly, regulatory fragmentation and the absence of harmonized legal definitions hinder their assessment and reimbursement policies, as well as their integration into healthcare systems. There is currently a lack of comprehensive overviews of DTx clinical development, which are essential for informing policy, research and regulatory priorities. This paper provides an updated overview of randomised clinical trials involving DTx. 254 eligible trials on DTx, (defined according to ISO/TR 11147:2023) registered through January 2025 were identified through a search on ClinicalTrials.gov. Mobile applications represent the most prevalent technology (65%), followed by web-based tools and virtual reality (20%). Psychiatric disorders are the primary therapeutic target (52% of the studies) with insomnia, depression, and anxiety being the most addressed conditions. Trials were primarily conducted in North America (41%) and Europe (32%), where Germany, Spain, and Italy represent the most active countries. The analysis of clinical trials registrations on ClinicalTrials.gov reveals a heterogenous geographical distribution of DTx development but also a clear direction in the type of conditions for which they are mostly indicated, namely psychiatric and nervous system disorders. The fragmented policies on DTx reimbursement, even among EU countries, and the different capacity of governments to fund DTx research and development emerge as key factors, along with cultural and ethical issues, in determining the willingness of the industry to invest in these devices. Author summary: When a software is intended by its manufacturer to treat, prevent, diagnose or monitor a pathologic condition, it cannot be considered as a general use product. Indeed, in most legislative framework, it is a Medical Device and, as such, it is subject to strict legislation which is in place to guarantee its safety and efficacy. Nomenclature, market access and reimbursement policies for such products vary worldwide, but there is wide acceptance of the term “Digital Therapeutics” (DTx) to mean software with a therapeutic function, as formalized by the ISO. In the paper we investigate, through the analysis of DTx clinical trials registrations in ClinicalTrials.gov, the regional distribution of active studies, the type of technology most actively researched (mobile app, web-based app, virtual reality or other) and the therapeutic indications. Our analysis highlighted on the one hand a heterogenous worldwide distribution of DTx, which reflects a fragmented landscape of reimbursement policies and funding capacity. On the other hand, a clear direction in both the type of technology employed (mobile apps) and in the prevalent therapeutic indications (psychiatric and nervous system disorders) clearly emerged.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Pharmaceutical Sciences, University of Milan, Milan, Italy",
    "INDICON S.r.l. Società Benefit, Milan, Italy"
  ],
  "article_type": "Research Article",
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Paolo Rocco"
    },
    {
      "affs": [
        1
      ],
      "name": "Valentina Pagella"
    },
    {
      "name": "Umberto M. Musazzi"
    },
    {
      "name": "Sara Manellari"
    },
    {
      "name": "Elena Paola Lanati"
    },
    {
      "name": "Paola Minghetti"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/fwgf30yzhgzck.bib",
  "cited_by": 0,
  "doi": "10.1371/journal.pdig.0001750",
  "fulltext_url": "https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001750",
  "id": "fwgf30yzhgzck",
  "issns": [
    "2767-3170"
  ],
  "landing_url": "https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001750",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "3202|Digital Mental Health Interventions"
    ],
    [
      "plos",
      "/Biology and life sciences/Anatomy/Nervous system"
    ],
    [
      "plos",
      "/Biology and life sciences/Bioengineering/Biotechnology/Medical devices and equipment"
    ],
    [
      "plos",
      "/Computer and information sciences/Computer architecture/User interfaces/Virtual reality"
    ],
    [
      "plos",
      "/Computer and information sciences/Software engineering/Computer software"
    ],
    [
      "plos",
      "/Engineering and technology/Bioengineering/Biotechnology/Medical devices and equipment"
    ],
    [
      "plos",
      "/Engineering and technology/Electronics engineering/Computer engineering/Man-computer interface/Virtual reality"
    ],
    [
      "plos",
      "/Engineering and technology/Software engineering/Computer software"
    ],
    [
      "plos",
      "/Medicine and health sciences/Anatomy/Nervous system"
    ],
    [
      "plos",
      "/Medicine and health sciences/Clinical medicine/Clinical trials"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical devices and equipment"
    ],
    [
      "plos",
      "/Medicine and health sciences/Mental health and psychiatry/Mental health therapies"
    ],
    [
      "plos",
      "/Medicine and health sciences/Oncology/Cancer treatment"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pharmacology/Drug research and development/Clinical trials"
    ],
    [
      "plos",
      "/People and places/Geographical locations/Europe"
    ],
    [
      "plos",
      "/Research and analysis methods/Clinical trials"
    ]
  ],
  "openalex": "W7221801721",
  "pdf_url": "https://journals.plos.org/digitalhealth/article/file?id=10.1371/journal.pdig.0001750&type=printable",
  "pmcid": "PMC13667809",
  "pmid": null,
  "published": "2026-10-01",
  "publisher": "Public Library of Science",
  "ris": "https://research.draconitic.com/paper/fwgf30yzhgzck.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:23Z",
      "native_id": "10.1371/journal.pdig.0001750",
      "source": "plos",
      "url": "https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001750"
    },
    {
      "first_seen": "2026-10-30T12:17:31Z",
      "native_id": "PMC:PMC13667809",
      "source": "europepmc",
      "url": "https://europepmc.org/article/PMC/PMC13667809"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "plos:biotechnology",
      "subfield": "systems-synthetic"
    },
    {
      "field": "medicine",
      "origin": "plos:clinical trials",
      "subfield": "clinical-trials"
    },
    {
      "field": "medicine",
      "origin": "plos:anatomy",
      "subfield": "physiology"
    }
  ],
  "title": "Pathologies and technologies for digital therapeutics: An analysis of global clinical trials",
  "title_text": "Pathologies and technologies for digital therapeutics: An analysis of global clinical trials",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:17:31Z",
  "url": "https://research.draconitic.com/paper/fwgf30yzhgzck",
  "venue": "PLOS Digital Health",
  "versions": []
}